A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)

Name: A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)
Published: 2013
License: Public Domain

Pfizer · 2013

ClinicalTrials.gov · Datasets · License: Public Domain · 2013

Open Source ↗

mtor

neoplasm, advanced cancer, solid tumors, pi3k, mtor, pi3k/mtor, metastatic, triple negative breast cancer (tnbc), interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)

Related documents